Issue 4 of SF Pulse is out now!
The newest issue dives into five topics including:
- A deep dive into how Johnson & Johnson starts thinking about anti-counterfeiting needs well before the product launch.
- An article by the Global Initiative Against Transnational Organized Crime highlighting the risks that an increased inflow of synthetic opioids, which are used in counterfeit and falsified medicines, could pose to Europe.
- A sneak peek of the Nigerian government’s successful efforts to curb the proliferation of substandard medicines in the Kano drug market.
- A report by Pharmarack Technologies Pvt. Ltd. on how the Indian pharmaceutical supply chain could combat the scourge of substandard medications.
- A blog post by Raffaella Ravinetto reflecting on a panel she participated in at last month’s World Health Summit in Berlin, on the role of rapid screening technologies in the fight against fake medicines.
Read the full issue here: https://bit.ly/4hZ7Rdx
SF Pulse is a bi-monthly newsletter that elevates important issues and relevant stories shaping the ongoing fight against substandard and falsified medical products (SFs).
